Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SABS

SAB Biotherapeutics Inc

Jun 11 • 04:00PM ET

3.38

+0.07 2.11 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: ELTX ENLV MGNX ABOS CAMP CNTX CRBP KRRO RNA TENX

| Held by: VTI VXF SURI AVSC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.47	Insider Own	25.35%	Shs Outstand	75.74M	Perf Week	-2.59%
Market Cap	258.45M	Forward P/E	-	EPS next Y	-0.66	Insider Trans	0.00%	Shs Float	57.08M	Perf Month	-6.63%
Enterprise Value	157.23M	PEG	-	EPS next Q	-0.27	Inst Own	76.60%	Short Float	4.63%	Perf Quarter	-26.36%
Income	-26.49M	P/S	-	EPS this Y	-22.20%	Inst Trans	21.71%	Short Ratio	3.67	Perf Half Y	-10.11%
Sales	0.00M	P/B	1.13	EPS next Y	31.34%	ROA	-18.49%	Short Interest	2.64M	Perf YTD	-9.63%
Book/sh	3.00	P/C	2.41	EPS next 5Y	3.43%	ROE	-21.31%	52W High	6.60 -48.79%	Perf Year	79.79%
Cash/sh	1.40	P/FCF	-	EPS past 3/5Y	43.07% -	ROIC	-11.39%	52W Low	1.60 111.25%	Perf 3Y	-62.86%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.17% 5.91%	Perf 5Y	-96.60%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	72.96%	Oper. Margin	-	ATR (14)	0.22	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	11.45	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	42.71	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	11.45	EPS Q/Q	37.01%	SMA20	-5.12%	Beta	0.56	Target Price	10.36
Payout	-	Debt/Eq	0.03	Sales Q/Q	-	SMA50	-8.57%	Rel Volume	0.32	Prev Close	3.31
Employees	86	LT Debt/Eq	0.02	Earnings	May 12 BMO	SMA200	-2.56%	Avg Volume	720.91K	Price	3.38
IPO	Feb 09, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	-64.71% -	Trades		Volume	239,761	Change	2.11%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)